New Kits Enable Rapid Labeling of Proteins and Other Macromolecules
By LabMedica International staff writers Posted on 17 Nov 2014 |
Image: Lightning-Link is an innovative technology that enables direct labeling of antibodies, proteins, peptides, or other biomolecules (Photo courtesy of Innova Biosciences).
Biotech or other life science researchers who prepare their own bioconjugated proteins, antibodies, or macromolecules will benefit from a new series of rapid labeling kits.
Innova Biosciences (Cambridge, United Kingdom), launched new antibody and protein labeling kits within its Lightning-Link Rapid range. These kits enable researchers to label primary antibodies or other proteins in about 20 minutes.
This range of kits include those for labeling molecules with high sensitivity Atto and Cy dyes as well as a rapid biotin conjugation kit. Boasting a reaction with an exceptionally short incubation time, the biotinylation kit yields conjugates with performance characteristics identical to, or better than, those prepared with laborious multistep conjugation procedures. Furthermore, the method does not require desalting or dialysis steps. Thus, Lightning-Link Rapid technology can be used to label small quantities of material with nearly 100% recovery.
Dr. Nick Gee, CEO of Innova, said: "The launch of the Lightning-Link kits completes the development of our Rapid conjugation range, and follows on from the success of the original kits, which had a much longer reaction time. This latest product introduction underlines Lightning-Link as one of the world’s leading bioconjugation technologies, offering easy-to-use labeling that provides excellent results with minimal hands on time and 100% yield.”
Related Links:
Innova Biosciences
Innova Biosciences (Cambridge, United Kingdom), launched new antibody and protein labeling kits within its Lightning-Link Rapid range. These kits enable researchers to label primary antibodies or other proteins in about 20 minutes.
This range of kits include those for labeling molecules with high sensitivity Atto and Cy dyes as well as a rapid biotin conjugation kit. Boasting a reaction with an exceptionally short incubation time, the biotinylation kit yields conjugates with performance characteristics identical to, or better than, those prepared with laborious multistep conjugation procedures. Furthermore, the method does not require desalting or dialysis steps. Thus, Lightning-Link Rapid technology can be used to label small quantities of material with nearly 100% recovery.
Dr. Nick Gee, CEO of Innova, said: "The launch of the Lightning-Link kits completes the development of our Rapid conjugation range, and follows on from the success of the original kits, which had a much longer reaction time. This latest product introduction underlines Lightning-Link as one of the world’s leading bioconjugation technologies, offering easy-to-use labeling that provides excellent results with minimal hands on time and 100% yield.”
Related Links:
Innova Biosciences
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples